Non-alcoholic fatty liver disease: the mist gradually clears.
about
Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemicNonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and managementRedox mechanisms in hepatic chronic wound healing and fibrogenesisGut Microbiota and Lifestyle Interventions in NAFLDExtragastric manifestations of Helicobacter pylori infection: Possible role of bacterium in liver and pancreas diseasesMechanisms of intrahepatic triglyceride accumulationFrom the stomach to other organs: Helicobacter pylori and the liverDiagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: consensus statement from the Study Group of Liver and Metabolism, Chinese Society of EndocrinologyTargeting autophagy for the treatment of liver diseasesEfficacy of Berberine in Patients with Non-Alcoholic Fatty Liver DiseaseAcute kidney injury and post-reperfusion syndrome in liver transplantationHepatocellular carcinoma in nonalcoholic fatty liver disease mimicking benign hemangioma: two case reports and literature reviewBiomarkers in nonalcoholic fatty liver disease-the emperor has no clothes?Apolipoprotein A-V dependent modulation of plasma triacylglycerol: a puzzlementLiver Patt1 deficiency protects male mice from age-associated but not high-fat diet-induced hepatic steatosisA cohort study of serum bilirubin levels and incident non-alcoholic fatty liver disease in middle aged Korean workersShugan Xiaozhi Decoction Attenuates Nonalcoholic Steatohepatitis by Enhancing PPARα and L-FABP Expressions in High-Fat-Fed RatsGenetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver diseaseNon-alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do.Importance of imaging and recent developments in diagnosis of nonalcoholic fatty liver disease.Radiologic evaluation of nonalcoholic fatty liver diseaseElevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey.Combined Adiponectin Deficiency and Resistance in Obese Patients: Can It Solve Part of the Puzzle in Nonalcoholic Steatohepatitis.Pathogenesis of non-alcoholic fatty liver disease.Dietary recommendations for patients with nonalcoholic fatty liver diseaseGender and racial differences in nonalcoholic fatty liver disease.Gender Differences in Bile Acids and Microbiota in Relationship with Gender Dissimilarity in Steatosis Induced by Diet and FXR Inactivation.Association between the hyperuricemia and nonalcoholic fatty liver disease risk in a Chinese population: A retrospective cohort study.Gene polymorphisms of cellular senescence marker p21 and disease progression in non-alcohol-related fatty liver diseasePeroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effectPediatric Non-Alcoholic Fatty Liver DiseaseA feed-forward loop amplifies nutritional regulation of PNPLA3Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options.Quantification of lipid droplets and associated proteins in cellular models of obesity via high-content/high-throughput microscopy and automated image analysis.Nonalcoholic fatty liver disease and HFE gene mutations: a Polish study.Gender difference in the impact of gynoid and android fat masses on the progression of hepatic steatosis in Japanese patients with type 2 diabetesRelationship of serum bilirubin concentration to kidney function and 24-hour urine protein in Korean adults.Prevalence of metabolic syndrome and risks of abnormal serum alanine aminotransferase in Hispanics: a population-based study.Synergy analysis reveals association between insulin signaling and desmoplakin expression in palmitate treated HepG2 cellsA switch in hepatic cortisol metabolism across the spectrum of non alcoholic fatty liver disease.
P2860
Q24563381-3F18A10B-DEFF-4559-A0AB-A36F442749BCQ24649618-B9BE1DE6-9770-4E06-8284-BDEC2CEAEDFEQ24656684-C149DFF4-0351-4916-8E78-2448952C7E9CQ26749783-73AD0F79-2BD6-4A5F-8C49-8AB9507D9DA2Q26771145-FFE17631-BFCD-47A7-B4A2-889E96FA456EQ26773198-CCFEE0D9-4F81-4E02-8F33-C8124A75434EQ26795532-9478AC2D-7386-4BBB-9C6D-E6FDB94C3CA8Q26998471-FEC17094-1F09-4718-9F6F-B7E6AA570CC6Q27014838-79A2D5FF-5832-413D-BD9F-2A711EEAD9A2Q27301440-0F798D02-DC40-45F2-9026-80B70FBACC89Q28074228-11AF1B2D-CD3D-4F50-B074-96DD3596A9F8Q28077023-EA8C5D3D-5B88-467E-AB40-3B2322775367Q28084035-9B9F454F-00C1-4CB0-87BD-805117976CDFQ28256394-26E4B3C4-2898-42BF-B016-5E2E862905FEQ28586093-D4C47D90-F780-4065-93F1-C67E66325B24Q28729949-8442A8BC-49EA-496B-8C84-ECFA23757981Q28817618-C48707C8-94E1-4314-A297-95A96663CE49Q29614897-F7239FF9-E103-4EE7-95E4-0B087AADA618Q30401022-B8F62A86-B9D0-447B-A9A4-0A24F247E899Q30413672-FC085021-ED6F-481E-A379-04D084D5DF6DQ30436162-CE1B97BA-3136-49C5-835E-AB2138562D39Q30572017-736BE7CA-9846-4A1D-A9B6-930BFB09D6BCQ33363300-17570197-C8A1-46D4-923E-9AC2C5356BB1Q33606303-1E48E701-6AD1-4146-B05D-B19D8386B156Q33636695-0A8EE4A1-96D4-4338-B5CC-771FC32EC489Q33660001-E5DCB493-FCEC-4B8B-A4DC-F914A480B781Q33687018-01CAF518-39C5-46F2-BEE1-F2D6A9C52AE2Q33693601-BF213D92-8DAE-40F1-BEF2-59CA35D978CCQ33728918-10917F0C-3F13-40AB-9B81-1E3C3D4EAF98Q33753420-FF3518AE-5453-445A-A761-01D99AF36476Q33831717-360B67F7-AEF6-4645-890A-E2AF5FE11780Q33842841-769EC53D-491B-4090-9766-67DF077A8E95Q33855157-8BC3F9BC-BAFC-41F6-B493-77CF178B2954Q33860061-AE706DEF-2D2E-4F32-B1C5-E64C9F2AB6E4Q33879464-E3416192-8500-4B60-9DBD-335D75611BACQ33892867-F89EA634-064A-40B5-863C-83261324C968Q33943931-6F6247AA-1593-4A2C-B9EA-AC61A3CF72ACQ33947985-DA9611FE-6508-4523-A8D3-3B6F57D61BF8Q34088181-DB1519B2-F801-458A-B379-03B718FE3256Q34169832-D11EDEF3-983E-4305-9CFB-63BB6DA2F503
P2860
Non-alcoholic fatty liver disease: the mist gradually clears.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Non-alcoholic fatty liver disease: the mist gradually clears.
@en
Non-alcoholic fatty liver disease: the mist gradually clears.
@nl
type
label
Non-alcoholic fatty liver disease: the mist gradually clears.
@en
Non-alcoholic fatty liver disease: the mist gradually clears.
@nl
prefLabel
Non-alcoholic fatty liver disease: the mist gradually clears.
@en
Non-alcoholic fatty liver disease: the mist gradually clears.
@nl
P1476
Non-alcoholic fatty liver disease: the mist gradually clears.
@en
P2093
Christopher Paul Day
Nimantha Mark Wilfred de Alwis
P304
P356
10.1016/J.JHEP.2008.01.009
P478
48 Suppl 1
P577
2008-02-04T00:00:00Z